Skip to main content
CME
NASDAQ Crypto Assets

CME Group Announces CEO Transition: Terry Duffy to Executive Chairman, Lynne Fitzpatrick to CEO in March 2027

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$254.44
Mkt Cap
$94.793B
52W Low
$244.56
52W High
$329.16
52W Position info
4.0% above low
Off High info
23% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CME is trading near its 52-week low of $244.56 (4.0% above the low).

Summary

CME Group announced a planned CEO transition for March 2027, with current CEO Terry Duffy becoming Executive Chairman and President and CFO Lynne Fitzpatrick being promoted to CEO.


Key Events · Executive and Board Changes · CME

  • CEO Transition Announced

    Terry Duffy, current Chairman and Chief Executive Officer, will transition to Executive Chairman.

  • New CEO Appointed

    Lynne Fitzpatrick, current President and Chief Financial Officer, will succeed Mr. Duffy as Chief Executive Officer.

  • Effective Date

    The leadership change is scheduled to become effective on the later of March 1, 2027, and the date the company files its Annual Report on Form 10-K for 2026.

  • Compensation Details

    The filing outlines the compensation structures for both Mr. Duffy as Executive Chairman and Ms. Fitzpatrick as the incoming CEO, including base salaries, bonus opportunities, and long-term incentives.


Analysis · CME · Crypto Assets

This 8-K details a planned leadership transition at CME Group, with long-serving CEO Terry Duffy moving to Executive Chairman and current President and CFO Lynne Fitzpatrick stepping into the CEO role. The transition, effective March 2027, signals a smooth internal succession and continuity in leadership for the global derivatives marketplace. The filing also outlines the compensation packages for both executives in their new roles.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.5% of the 1993 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CME was trading at $254.44 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $94.8B. The 52-week trading range was $244.56 to $329.16. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CME - Latest Insights

CME
Sep 10, 2026, 11:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $275.20
Real-time Price: $275.00 info
Change: -$0.200 (-0.07%) info
Market Cap: $98.55B info
CME
Sep 09, 2026, 12:17 PM EDT
Source: The Block
Importance Score:
7
Price at Filing: $275.22
Real-time Price: $275.00 info
Change: -$0.220 (-0.08%) info
Market Cap: $98.55B info
CME
Sep 02, 2026, 11:39 PM EDT
Source: The Block
Importance Score:
7
Price at Filing: $278.15
Real-time Price: $275.00 info
Change: -$3.15 (-1%) info
Market Cap: $98.55B info
CME
Aug 12, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $259.00
Real-time Price: $275.00 info
Change: +$16.00 (+6%) info
Market Cap: $98.55B info
CME
Jul 22, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $239.87
Real-time Price: $275.00 info
Change: +$35.13 (+15%) info
Market Cap: $98.55B info